185 related articles for article (PubMed ID: 12645814)
21. Three Pathways of Colonic Carcinogenesis in Rats.
Rubio CA
Anticancer Res; 2017 Jan; 37(1):15-20. PubMed ID: 28011469
[TBL] [Abstract][Full Text] [Related]
22. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
[TBL] [Abstract][Full Text] [Related]
23. ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy.
Brand L; Munding J; Pox CP; Ziebarth W; Reiser M; Hüppe D; Schmiegel W; Reinacher-Schick A; Tannapfel A
Int J Colorectal Dis; 2013 Aug; 28(8):1091-8. PubMed ID: 23516071
[TBL] [Abstract][Full Text] [Related]
24. The use of early and midpoint adenoma-carcinoma sequence biomarkers in prediction of neoplastic progression in patients with a history of colorectal neoplasia.
Albataineh H; Yordanova V; Bowman J; Zhou W; Hatfield J; Lawson MJ; Sochacki P; Tobi M
Dig Dis Sci; 2006 Dec; 51(12):2213-9. PubMed ID: 17080251
[TBL] [Abstract][Full Text] [Related]
25. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
26. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas.
Sugai T; Nakamura SI; Habano W; Uesugi N; Sato H; Yoshida T; Orii S
Pathol Int; 1999 Jul; 49(7):617-25. PubMed ID: 10504522
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
[TBL] [Abstract][Full Text] [Related]
31. [Coexpression of CD44 and Ki-67 in colon`s neoplast].
Oleynikova NA; Kharlova OA; Malkov PG; Danilova NV
Arkh Patol; 2018; 80(1):27-36. PubMed ID: 29460892
[TBL] [Abstract][Full Text] [Related]
32. Hyperplastic polyps and serrated adenomas: precancerous lesions with mixed immunophenotype.
Pap Z; Pávai Z; Dénes L; Brînzaniuc K; Jung I
Rom J Morphol Embryol; 2011; 52(3):797-802. PubMed ID: 21892521
[TBL] [Abstract][Full Text] [Related]
33. High frequency of p53 expression in colo-rectal adenomatous polyps.
Boccuzzi A; Terzolo M; Leonardo E; Cappia S; Tappero G; Paccotti P; Angeli A
Anticancer Res; 1995; 15(4):1407-10. PubMed ID: 7654029
[TBL] [Abstract][Full Text] [Related]
34. Expression of Ki-67 and cytokeratin 20 in hyperplastic polyps of the colorectum.
Davenport A; Hale RJ; Hunt CR; Bigley G; McMahon RF
J Clin Pathol; 2003 Mar; 56(3):200-4. PubMed ID: 12610098
[TBL] [Abstract][Full Text] [Related]
35. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa.
Johnston PG; O'Brien MJ; Dervan PA; Carney DN
Hum Pathol; 1989 Jul; 20(7):696-700. PubMed ID: 2661411
[TBL] [Abstract][Full Text] [Related]
37. [The malignancy potential of colorectal polyps--histomorphometric, histochemical and immunohistochemical study of the dysplasia-carcinoma sequence].
Dippe B; Petrowsky H; Krüger S; von Jentzkowski K; Schneider M; Lorenz M
Zentralbl Chir; 1995; 120(7):556-63. PubMed ID: 7676754
[TBL] [Abstract][Full Text] [Related]
38. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
[TBL] [Abstract][Full Text] [Related]
39. Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody.
Tobi M; Elitsur Y; Moyer MP; Halline A; Deutsch M; Nochomovitz L; Luk GD
Scand J Gastroenterol; 1993 Dec; 28(12):1025-34. PubMed ID: 8303203
[TBL] [Abstract][Full Text] [Related]
40. Fecal Adnab-9 binding as a risk marker for colorectal neoplasia.
Yuan M; Xhang X; Leu Y; Xu Y; Ullah N; Lawson M; Tobi M
Cancer Lett; 2006 Apr; 235(1):48-52. PubMed ID: 15893419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
